Delivery Order SPE2DB22D1202-SPE2DB23FHPN3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,355.52 firm fixed-price delivery order contract is for the supply of 4,566,197,995 units of Citalopram HBR 40 mg tablets. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,756,354 units of Citalopram HBR 40 mg tablets. The Firm Fixed Price delivery order, valued at $1,997.07, has an ultimate completion date of August 10, 2023. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). The contract award is not...
- This federal contract award, valued at $32,265.60, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of 4,564,861,519 units of the pharmaceutical drug Citalopram HBR 40 mg tablet, with a period of performance through June 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,474.36 firm fixed-price delivery order is for the supply of Citalopram HBr 40 mg tablets. The contract has an ultimate completion date of November 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, with ID SPE2DB20D2200|SPE2DB23FW98R, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,188.25 firm fixed-price delivery order is for the supply of 4,562,071 units of Citalopram HBR 40 mg tablets. The contract has an ultimate completion date of September 7, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of citalopram HBR 20 mg tablets to the Defense Logistics Agency (DLA). The $2,513.74 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of May 11, 2023 and is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $20,622.55, is a delivery order awarded by the Defense Logistics Agency (DLA) for the supply of 4,566,066,792 tablets of Citalopram HBR 40 mg. The contract has an ultimate completion date of October 10, 2024 and is a firm fixed-price contract. Amerisourcebergen, through its Corporate Office division, is the prime contractor for this award, which is not...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D1100|SPE2DB24FZ46Z) from the Defense Logistics Agency (DLA) Troop Support Medical. The $14,876.66 firm fixed-price contract is for the delivery of 4563189362 units of Citalopram HBR 40 mg tablets, with a completion date of December 28, 2023. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly...
- This federal contract award is for the delivery of 4,563,905,445 units of Citalopram HBR 20 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $9,099.76 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a performance period through March 11, 2024 and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $4,301.24 firm fixed-price delivery order is for the supply of 4,565,911,141 citalopram hydrochloride 40 milligram tablets, an antidepressant medication. The contract has a completion date of September 24, 2024 and does not utilize a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FHPN3Delivery Order
This federal contract award is for the delivery of Citalopram HBR 40mg tablets by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,323.48 firm-fixed-price delivery order was placed by the Defense Logistics Agency (DLA) on May 15, 2023, with a completion date of May 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract also encompasses a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse pharmaceutical needs of multiple government agencies on a large scale. The contract award reviewed does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 5/15/23 |